PRA-180351 Autism Spectrum Disorder (ASD) € 4.000,-

Many places available

Description

Study of a new compound that is being developed for the treatment of Autism Spectrum Disorder (ASD)

Requested participants

  • M/F, gezond, 18 - 65 years old
  • Non-smokers only

Duration and visits

  • 34 days stay

Learn more about this research?

Research details

Particulars

  • Your Body Mass Index (BMI) is between 18 and 30 kg/m2. The BMI shows the relation between body weight in kilograms and height in meters.
  • Women are only allowed to participate in this study if they are using sufficient contraception or have been postmenopausal for at least one year or have been surgically sterilized.
  • To determine if you are suitable to participate in this study, you will undergo a medical screening.
Calculate BMI

Compensation

You will receive a gross compensation of € 3.361,- for participation in one of the groups of this study.

Travelling expenses will be reimbursed based on the distance traveled (€0,19 net per kilometer) with a minimum of €12,- and a maximum of €160,- (840 kilometers) per return, regardless of the mode of transportation.

Period of stay and research

The study consists of 2 periods. For period 1 you will stay in our research facility for 12 days (11 nights) and for period 2 you will stay for 17 days (16 nights) in our research facility in Groningen, location UMCG.

Please note: You have to be available for all dates for the group of choice to be able to participate in this study. These are the currently planned dates; however, these may be subject to change.

Group 2a

€ 4.000,-

34 days stay

  • 10 Sep 2018 up to and including 21 Sep 2018
  • 27 Sep 2018 up to and including 18 Oct 2018

short stay

Inapplicable

Group 2b

€ 4.000,-

34 days stay

  • 13 Sep 2018 up to and including 24 Sep 2018
  • 30 Sep 2018 up to and including 21 Oct 2018

short stay

Inapplicable

Call me back

We bellen terug tijdens kantooruren binnen 3 werkdagen.

Bel mij terug
  • ?

  • ?